Pfizer, Plaintiffs Spar Over Evidence
With the first trial in the multidistrict litigation over Pfizer's arthritis drugs Celebrex and Bextra on the horizon, both sides have filed motions seeking to limit the scope of evidence about...To view the full article, register now.
Already a subscriber? Click here to view full article